Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: HEAD AND NECK CANCER, . Treffer: 53

2020

Vasicek, SM; Pondorfer, P; Holzmeister, C; Graupp, M; Weiland, T; Wolf, A; Moser, U; Wild, D; Thurnher, D Head and neck cancer in Styria : An epidemiologic and clinical audit.
Wien Klin Wochenschr. 2020; [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Gsaxner, C; Wallner, J; Chen, X; Zemann, W; Egger, J Facial model collection for medical augmented reality in oncologic cranio-maxillofacial surgery.
Sci Data. 2019; 6(1): 310-310. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pepe, A; Trotta, GF; Mohr-Ziak, P; Gsaxner, C; Wallner, J; Bevilacqua, V; Egger, J A Marker-Less Registration Approach for Mixed Reality-Aided Maxillofacial Surgery: a Pilot Evaluation.
J Digit Imaging. 2019; 32(6): 1008-1018. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Richtig, G; Aigelsreiter, AM; Asslaber, M; Weiland, T; Pichler, M; Eberhard, K; Sygulla, S; Schauer, S; Hoefler, G; Aigelsreiter, A Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma.
Histopathology. 2019; 75(1):118-127 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Dietz, A; Wichmann, G; Kuhnt, T; Pfreundner, L; Hagen, R; Scheich, M; Kölbl, O; Hautmann, MG; Strutz, J; Schreiber, F; Bockmühl, U; Schilling, V; Feyer, P; de Wit, M; Maschmeyer, G; Jungehülsing, M; Schroeder, U; Wollenberg, B; Sittel, C; Münter, M; Lenarz, T; Klussmann, JP; Guntinas-Lichius, O; Rudack, C; Eich, HT; Foerg, T; Preyer, S; Westhofen, M; Welkoborsky, HJ; Esser, D; Thurnher, D; Remmert, S; Sudhoff, H; Görner, M; Bünzel, J; Budach, V; Held, S; Knödler, M; Lordick, F; Wiegand, S; Vogel, K; Boehm, A; Flentje, M; Keilholz, U Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Ann Oncol. 2018; 29(10): 2105-2114. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Simon, C; Caballero, C; Gregoire, V; Thurnher, D; Koivunen, P; Ceruse, P; Spriano, G; Nicolai, P; Licitra, L; Machiels, JP; Hamoir, M; Andry, G; Mehanna, H; Hunter, KD; Dietz, A; René Leemans, C Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study.
EUR J CANCER. 2018; 103: 69-77.
Web of Science PubMed FullText FullText_MUG

 

2017

Kotowski, U; Heiduschka, G; Kadletz, L; Fahim, T; Seemann, R; Schmid, R; Schneider, S; Mitterbauer, A; Thurnher, D Effect of thymoquinone on head and neck squamous cell carcinoma cells in vitro: Synergism with radiation.
Oncol Lett. 2017; 14(1):1147-1151 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kotowski, U; Kadletz, L; Schneider, S; Foki, E; Schmid, R; Seemann, R; Thurnher, D; Heiduschka, G 6-shogaol induces apoptosis and enhances radiosensitivity in head and neck squamous cell carcinoma cell lines.
Phytother Res. 2017;
Web of Science PubMed FullText FullText_MUG

 

2016

Bertl, K; Loidl, S; Kotowski, U; Heiduschka, G; Thurnher, D; Stavropoulos, A; Schneider-Stickler, B Oral health status and dental care behaviours of head and neck cancer patients: a cross-sectional study in an Austrian tertiary hospital.
Clin Oral Investig. 2016; 20(6):1317-1327 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schneider, S; Thurnher, D; Kadletz, L; Seemann, R; Brunner, M; Kotowski, U; Schmid, R; Lill, C; Heiduschka, G Effects of neratinib and combination with irradiation and chemotherapy in head and neck cancer cells.
Oral Dis. 2016; 22(8):797-804
Web of Science PubMed FullText FullText_MUG

 

Selzer, E; Grah, A; Heiduschka, G; Kornek, G; Thurnher, D Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Wien Klin Wochenschr. 2016; 128(9-10):320-328 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Heiduschka, G; Grah, A; Oberndorfer, F; Kadletz, L; Altorjai, G; Kornek, G; Wrba, F; Thurnher, D; Selzer, E Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy.
Strahlenther Onkol. 2015; 191(3):209-216
Web of Science PubMed FullText FullText_MUG

 

Kotowski, U; Heiduschka, G; Seemann, R; Eckl-Dorna, J; Schmid, R; Kranebitter, V; Stanisz, I; Brunner, M; Lill, C; Thurnher, D Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines.
Strahlenther Onkol. 2015; 191(6):511-517
Web of Science PubMed FullText FullText_MUG

 

Selzer, E; Grah, A; Heiduschka, G; Kornek, G; Thurnher, D Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer: Comparative analysis of inflammation-based prognostic scoring systems.
Strahlenther Onkol. 2015; 191(6):486-494
Web of Science PubMed FullText FullText_MUG

 

2014

Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, AL; Koller, K; Salzwimmer, M; Gerger, A; Schauer, S; Bauernhofer, T; Pichler, M Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Hum Pathol. 2014; 45(4):683-690
Web of Science PubMed FullText FullText_MUG

 

Heiduschka, G; Grah, A; Oberndorfer, F; Seemann, R; Kranz, A; Kornek, G; Wrba, F; Thurnher, D; Selzer, E Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab.
Strahlenther Onkol. 2014; 190(9):832-838
Web of Science PubMed FullText FullText_MUG

 

Heiduschka, G; Lill, C; Schneider, S; Seemann, R; Kornek, G; Schmid, R; Kotowski, U; Thurnher, D The effect of cilengitide in combination with irradiation and chemotherapy in head and neck squamous cell carcinoma cell lines.
Strahlenther Onkol. 2014; 190(5): 472-479.
Web of Science PubMed FullText FullText_MUG

 

Quinten, C; Martinelli, F; Coens, C; Sprangers, MA; Ringash, J; Gotay, C; Bjordal, K; Greimel, E; Reeve, BB; Maringwa, J; Ediebah, DE; Zikos, E; King, MT; Osoba, D; Taphoorn, MJ; Flechtner, H; Schmucker-Von Koch, J; Weis, J; Bottomley, A; Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
Cancer. 2014; 120(2):302-311 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Robinson, M; Suh, YE; Paleri, V; Devlin, D; Ayaz, B; Pertl, L; Thavaraj, S Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population.
Infect Agent Cancer. 2013; 8(1):30-30 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Kotowski, U; Heiduschka, G; Brunner, M; Erovic, BM; Martinek, H; Thurnher, D Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines.
Oncol Lett. 2012; 3(6):1326-1330 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Bauernhofer, T; Pichler, M; Wieckowski, E; Stanson, J; Aigelsreiter, A; Griesbacher, A; Groselj-Strele, A; Linecker, A; Samonigg, H; Langner, C; Whiteside, TL Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.
Br J Cancer. 2011; 104(10):1641-1648 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kotowski, U; Heiduschka, G; Brunner, M; Czembirek, C; Eder-Czembirek, C; Schmidt, R; Fahim, T; Thurnher, D Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane.
Strahlenther Onkol. 2011; 187(9):575-580
Web of Science PubMed FullText FullText_MUG

 

Lill, C; Kornek, G; Bachtiary, B; Selzer, E; Schopper, C; Mittlboeck, M; Burian, M; Wrba, F; Thurnher, D Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced.
Wien Klin Wochenschr. 2011; 123(7-8):215-221
Web of Science PubMed FullText FullText_MUG

 

Schneider, S; Thurnher, D; Kloimstein, P; Leitner, V; Petzelbauer, P; Pammer, J; Brunner, M; Erovic, BM Expression of the Sonic hedgehog pathway in squamous cell carcinoma of the skin and the mucosa of the head and neck.
Head Neck. 2011; 33(2):244-250
Web of Science PubMed FullText FullText_MUG

 

2010

Ausweger, C; Burgschwaiger, E; Kugler, A; Schmidbauer, R; Steinek, I; Todorov, Y; Thurnher, D; Krapfenbauer, K Economic concerns about global healthcare in lung, head and neck cancer: meeting the economic challenge of predictive, preventive and personalized medicine.
EPMA J. 2010; 1(4):627-631 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Brunner, M; Erovic, B; Heiduschka, G; Schneider, S; Pammer, J; Frantal, S; Thurnher, D RCAS-1 serum and tumor levels in head and neck squamous cell carcinoma.
Eur Surg Res. 2010; 44(3-4):214-219
Web of Science PubMed FullText FullText_MUG

 

Eder-Czembirek, C; Erovic, BM; Czembirek, C; Brunner, M; Selzer, E; Pötter, R; Thurnher, D Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines.
Strahlenther Onkol. 2010; 186(3):143-148
Web of Science PubMed FullText FullText_MUG

 

Feichtinger, M; Pau, M; Zemann, W; Aigner, RM; Kärcher, H Intraoperative control of resection margins in advanced head and neck cancer using a 3D-navigation system based on PET/CT image fusion.
J Craniomaxillofac Surg. 2010; 38(8): 589-594.
Web of Science PubMed FullText FullText_MUG

 

Haas, HS; Linecker, A; Pfragner, R; Sadjak, A Peripheral glutamate signaling in head and neck areas.
Head Neck. 2010; 32(11): 1554-1572.
Web of Science PubMed FullText FullText_MUG

 

Tomuleasa, C; Soritau, O; Brie, I; Pall, E; Foris, V; Dicu, T; Virag, P; Irimie, A; Kacso, G Mesenchymal stem cell irradiation in culture engages differential effect of hyper-fractionated radiotherapy for head and neck cancers.
J BUON. 2010; 15(2):348-356
Web of Science PubMed

 

2009

Heiduschka, G; Erovic, BM; Vormittag, L; Skoda, C; Martinek, H; Brunner, M; Ehrenberger, K; Thurnher, D 7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg. 2009; 135(3):261-267
Web of Science PubMed FullText FullText_MUG

 

Kohlfurst, S; Markitz, M; Raunik, W; Eckel, HE; Kresnik, E; Hausegger, K; Salzwimmer, M; Gaggl, A; Chiari, F; Lind, P Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference
LARYNGO RHINO OTOL. 2009; 88(2): 84-90.
Web of Science PubMed FullText FullText_MUG

 

2008

Erovic, BM; Woegerbauer, M; Pammer, J; Selzer, E; Grasl, MCh; Thurnher, D Strong evidence for up-regulation of cyclooxygenase-1 in head and neck cancer.
Eur J Clin Invest. 2008; 38(1):61-66
Web of Science PubMed FullText FullText_MUG

 

Skoda, C; Erovic, BM; Wachek, V; Vormittag, L; Wrba, F; Martinek, H; Heiduschka, G; Kloimstein, P; Selzer, E; Thurnher, D Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck.
Oncol Rep. 2008; 19(6):1499-1503
Web of Science PubMed

 

2007

Thurnher, D; Novak, CB; Neligan, PC; Gullane, PJ Reconstruction of lateral skull base defects after tumor ablation.
Skull Base. 2007; 17(1):79-88 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2005

Czembirek, C; Eder-Czembirek, C; Erovic, BM; Turhani, D; Selzer, E; Thurnher, D Inhibition of cytotoxicity of cisplatin by cyclooxygenase-2 inhibitor nimesulide in head and neck cancer cell lines.
Oncol Rep. 2005; 14(6):1523-1526
Web of Science PubMed

 

Eder-Czembirek, C; Czembirek, C; Erovic, BM; Selzer, E; Turhani, D; Vormittag, L; Thurnher, D Combination of betulinic acid with cisplatin--different cytotoxic effects in two head and neck cancer cell lines.
Oncol Rep. 2005; 14(3):667-671
Web of Science PubMed

 

Erovic, BM; Pelzmann, M; Grasl, MCh; Pammer, J; Kornek, G; Brannath, W; Selzer, E; Thurnher, D Mcl-1, vascular endothelial growth factor-R2, and 14-3-3sigma expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
Clin Cancer Res. 2005; 11(24 Pt 1):8632-8636 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lamm, W; Vormittag, L; Turhani, D; Erovic, BM; Czembirek, C; Eder-Czembirek, C; Thurnher, D The effect of nimesulide, a selective cyclooxygenase-2 inhibitor, on Ets-1 and Ets-2 expression in head and neck cancer cell lines.
Head Neck. 2005; 27(12):1068-1072
Web of Science PubMed FullText FullText_MUG

 

Vormittag, L; Lamm, W; Erovic, BM; Czembirek, C; Kornek, G; Thurnher, D Expression levels of Akt in nimesulide-treated squamous carcinoma cell lines of the head and neck.
Oncol Rep. 2005; 13(2):207-210
Web of Science PubMed

 

2004

Pelzmann, M; Thurnher, D; Gedlicka, C; Martinek, H; Knerer, B Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
J Oral Pathol Med. 2004; 33(10):607-613
Web of Science PubMed FullText FullText_MUG

 

2003

Bauernhofer, T; Kuss, I; Henderson, B; Baum, AS; Whiteside, TL Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer.
EUR J IMMUNOL. 2003; 33: 119-124.
Web of Science PubMed FullText FullText_MUG

 

2002

Lang, S; Wollenberg, B; Dellian, M; Steuer-Vogt, MK; Schwenzer, K; Sautier, W; Chucholowski, M; Eckel, R; Faas, I; Wilmes, E; Ehrenfeld, M; Arnold, W; Kastenbauer, E; Hölzel, D Clinical and epidemiological data of patients with malignomas of the head and neck].
Laryngorhinootologie. 2002; 81(7):499-508
Web of Science PubMed FullText FullText_MUG

 

2001

Thurnher, D; Bakroeva, M; Formanek, M; Knerer, B; Kornfehl, J Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines.
Head Neck. 2001; 23(12):1049-1055
Web of Science PubMed FullText FullText_MUG

 

Thurnher, D; Bakroeva, M; Schütz, G; Pelzmann, M; Formanek, M; Knerer, B; Kornfehl, J Non-steroidal anti-inflammatory drugs induce apoptosis in head and neck cancer cell lines.
Acta Otolaryngol. 2001; 121(8):957-962
Web of Science PubMed FullText FullText_MUG

 

Thurnher, D; Kornfehl, J; Burian, M; Gedlicka, C; Selzer, E; Quint, C; Neuchrist, C; Kornek, GV Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Anticancer Drugs. 2001; 12(3):205-208
Web of Science PubMed FullText FullText_MUG

 

1999

Danninger, R; Posawetz, W; Humer, U; Stammberger, H; Jakse, R Ultrasound investigation of cervical lymph node metastases: Conception and results of a histopathological exploration
LARYNGO RHINO OTOL. 1999; 78(3): 144-149.
Web of Science FullText FullText_MUG Google Scholar

 

1998

Thödtmann, F; Theiss, F; Kemmerich, M; Heinrich, B; Laubenbacher, C; Quasthoff, S; Kau, R; Herzog, M; Diergarten, K; Hanauske, AR Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck.
Ann Oncol. 1998; 9(3):335-337 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Thurnher, D; Knerer, B; Formanek, M; Kornfehl, J Non-radioactive semiquantitative testing for the expression levels of telomerase activity in head and neck squamous cell carcinomas may be indicative for biological tumour behaviour.
Acta Otolaryngol. 1998; 118(3):423-427
Web of Science PubMed

 

1997

Schilling, T; Heinrich, B; Kau, R; Herzog, M; Quasthoff, S; Diergarten, K; Rastetter, J; Hanauske, AR Paclitaxel administered over 3 h followed by cisplatin in patients with advanced head and neck squamous cell carcinoma: a clinical phase I study.
Oncology. 1997; 54(2):89-95
Web of Science PubMed

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum